BrainStorm Cell Therapeutics Inc. (BCLI) stock
BCLIOTCBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 0/30
$0.77−0.01 (-1.17%)
Close on Oct 19, 2026Market cap $8.50MP/E –Yield –
BrainStorm Cell Therapeutics price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
BrainStorm Cell Therapeutics's price to book ratio was 47.9× on Jan 31, 2023, against 4.5× a year earlier. Over the last 5 years it ranged from 3.4× to 264.4×, with a median of 10.2×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2023 | Jan 31, 2023 | 47.9× | +4.7 |
| 2022 | Dec 30, 2022 | 43.2× | +37.4 |
| 2021 | Dec 31, 2021 | 5.8× | +0.3 |
| 2020 | Dec 31, 2020 | 5.5× | −258.8 |
| 2019 | Jul 31, 2019 | 264.4× | +257.0 |
| 2018 | Dec 31, 2018 | 7.4× | −6.9 |
| 2017 | Dec 29, 2017 | 14.2× | +9.7 |
| 2016 | Dec 30, 2016 | 4.5× | +1.1 |
| 2015 | Dec 31, 2015 | 3.4× | −4.7 |
| 2014 | Dec 31, 2014 | 8.1× | +1.1 |
| 2013 | Dec 31, 2013 | 7.0× | −0.4 |
| 2012 | Dec 31, 2012 | 7.4× | −3.9 |
| 2011 | Dec 30, 2011 | 11.3× | – |
See a number that looks wrong?